Table 1.

Overview of reported diseased DADA2 carriers in literature

StudyAge at onset (years)ADA2 genotypeClinical phenotypeADA2 activityTreatment
Zhou et al. (1) Adulthood p.Y453C/WT Small vessel ischemic stroke Unknown Unknown 
Zhou et al. (1) Adulthood p.Y453C/WT Hypertension, small vessel ischemic stroke Unknown Warfarin 
Rama et al. (130) p.G47R/WT Recurrent fever, elevated CRP levels, cephalgia, arthralgia, myalgia, papular rash with pruritic and GI manifestations Carrier range Unknown 
Nihira et al. (120) 10 p.E328K/WT Fever, intracranial hemorrhage, cerebral infarction, livedo racemosa, splenomegaly, and renal infarction Low Infliximab and SCIG replacement 
Nihira et al. (120) 12 p.E328K/WT Diplopia, memory disturbances, livedo racemosa, and renal infarction Low Infliximab and SCIG replacement 
Schnappauf et al. (106) Adulthood p.Y453C/WT PAN with fever, cutaneous ulcers, and neuropathy High carrier range Unknown 
Moi et al. (131) Childhood p.R169Q/WT Arthritis, recurrent infections, and common variable immunodeficiency Carrier range IVIG replacement 
Celikel et al. (134) 1.5 p.G47R/WT Recurrent fever, elevated CRP levels, and anemia Unknown Etanercept 
Izumo et al. (132) p.F355L/p.Y453C Elevated CRP levels, livedo, and multiple cerebral infarctions Carrier range Infliximab 
Pulvirenti et al. (129) 12 p.Y453C/WT Fever, skin rash, hypogammaglobulinemia, and lymphadenitis Unknown No treatment 
Yilmaz et al. (133) 20 p.R49Afs*13/WT Crohn’s disease Carrier range Surgery plan 

or Create an Account

Close Modal
Close Modal